Skip to main content
. 2018 Jul 13;97(28):e11343. doi: 10.1097/MD.0000000000011343

Figure 3.

Figure 3

NRXN3 expression levels in AD patients and healthy controls (A) and the 3 age groups (B) were significantly different (FDR-value < 0.05).